Compass Wealth Management’s Novartis NVS Stock Holding History

Compass Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Sell	12,747 -100	-0.8%	-$15K	0.38%	71
2026 Q1	$1.96M	Sell	12,847 -100	-0.8%	-$15.3K	0.49%	62
2025 Q4	$1.79M	Sell	12,947 -250	-2%	-$32.7K	0.45%	63
2025 Q3	$1.69M	Sell	13,197 -125	-0.9%	-$15.3K	0.38%	70
2025 Q2	$1.61M	Sell	13,322 -878	-6%	-$99K	0.38%	71
2025 Q1	$1.58M	Sell	14,200 -800	-5%	-$85.2K	0.4%	72
2024 Q4	$1.46M	Sell	15,000 -1,625	-10%	-$173K	0.35%	75
2024 Q3	$1.91M	Sell	16,625 -950	-5%	-$108K	0.45%	71
2024 Q2	$1.87M	Sell	17,575 -50	-0.3%	-$5.02K	0.46%	71
2024 Q1	$1.7M	Sell	17,625 -660	-4%	-$67.7K	0.43%	74
2023 Q4	$1.85M	Buy	18,285 +435	+2%	+$42K	0.52%	65
2023 Q3	$1.82M	Sell	17,850 -350	-2%	-$35.5K	0.57%	59
2023 Q2	$1.84M	Sell	18,200 -150	-0.8%	-$15K	0.55%	60
2023 Q1	$1.69M	Hold	18,350	–	–	0.54%	65
2022 Q4	$1.66M	Buy	+18,350	New	+$1.55M	0.55%	63

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Compass Wealth Management's NVS Position: Q2 2026 in Review

Compass Wealth Management reduced its Novartis (NVS) stake by 0.78% in Q2 2026, selling an estimated $15K and leaving 12,747 shares worth $2M. The position accounts for 0.38% of the portfolio, ranked #71.

Compass Wealth Management first reported a position in NVS in Q4 2022 and has held it in 15 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Compass Wealth Management held 12,747 shares of Novartis worth $2M as of Q2 2026.
Compass Wealth Management sold 100 Novartis shares in Q2 2026, an estimated $15K.
Novartis made up 0.38% of Compass Wealth Management's portfolio in Q2 2026, its #71 holding.
Compass Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 15 quarters since.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Compass Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.